415 related articles for article (PubMed ID: 29146238)
1. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
[TBL] [Abstract][Full Text] [Related]
2. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
[TBL] [Abstract][Full Text] [Related]
3. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
4. Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.
Fitting S; Stevens DL; Khan FA; Scoggins KL; Enga RM; Beardsley PM; Knapp PE; Dewey WL; Hauser KF
J Pharmacol Exp Ther; 2016 Jan; 356(1):96-105. PubMed ID: 26542403
[TBL] [Abstract][Full Text] [Related]
5. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
[TBL] [Abstract][Full Text] [Related]
6. Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.
Hahn YK; Paris JJ; Lichtman AH; Hauser KF; Sim-Selley LJ; Selley DE; Knapp PE
Neurobiol Dis; 2016 Aug; 92(Pt B):124-36. PubMed ID: 26845176
[TBL] [Abstract][Full Text] [Related]
7. Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.
Dutta R; Roy S
J Neuroinflammation; 2015 Jun; 12():120. PubMed ID: 26087960
[TBL] [Abstract][Full Text] [Related]
8. Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist.
Nayak SU; Cicalese S; Tallarida C; Oliver CF; Rawls SM
Brain Behav Immun; 2020 Jan; 83():288-292. PubMed ID: 31557508
[TBL] [Abstract][Full Text] [Related]
9. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
[TBL] [Abstract][Full Text] [Related]
10. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
11. Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription.
El-Hage N; Bruce-Keller AJ; Yakovleva T; Bazov I; Bakalkin G; Knapp PE; Hauser KF
PLoS One; 2008; 3(12):e4093. PubMed ID: 19116667
[TBL] [Abstract][Full Text] [Related]
12. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
13. Morphine enhances Tat-induced activation in murine microglia.
Bokhari SM; Yao H; Bethel-Brown C; Fuwang P; Williams R; Dhillon NK; Hegde R; Kumar A; Buch SJ
J Neurovirol; 2009 May; 15(3):219-28. PubMed ID: 19462331
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine.
Duncan MJ; Bruce-Keller AJ; Conner C; Knapp PE; Xu R; Nath A; Hauser KF
Am J Physiol Regul Integr Comp Physiol; 2008 Nov; 295(5):R1680-7. PubMed ID: 18784333
[TBL] [Abstract][Full Text] [Related]
15. Depressive-like Behavior Is Accompanied by Prefrontal Cortical Innate Immune Fatigue and Dendritic Spine Losses after HIV-1 Tat and Morphine Exposure.
Nass SR; Hahn YK; Ohene-Nyako M; McLane VD; Damaj MI; Thacker LR; Knapp PE; Hauser KF
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992299
[TBL] [Abstract][Full Text] [Related]
16. A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.
El-Hage N; Dever SM; Podhaizer EM; Arnatt CK; Zhang Y; Hauser KF
AIDS; 2013 Sep; 27(14):2181-90. PubMed ID: 23751259
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.
El-Hage N; Wu G; Wang J; Ambati J; Knapp PE; Reed JL; Bruce-Keller AJ; Hauser KF
Glia; 2006 Jan; 53(2):132-46. PubMed ID: 16206161
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid CB
Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation.
Merino JJ; Muñetón-Gomez V; Muñetón-Gómez C; Pérez-Izquierdo MÁ; Loscertales M; Toledano Gasca A
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32024104
[TBL] [Abstract][Full Text] [Related]
20. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
